傳美國成功促使荷蘭阻止半導體設備出口中國
《路透》引述消息報道,美國國務卿蓬佩奧遊說荷蘭政府,試圖阻止荷蘭半導體設備商艾司摩爾(ASML)向中國出售晶片設備。
報道指,有關行動於2018年展開,當時荷蘭政府批准艾司摩爾向中國客戶出售最新設備,美國政府其後檢視能否阻止交易,並與荷蘭官員進行4輪商討。美國副國家安全顧問Charles Kupperman在與荷蘭總理魯特(Mark Rutte)會面期間,向荷蘭官員提出有關問題。蓬佩奧其後亦直接要求魯特阻止交易,荷蘭其後停止延續艾司摩爾的出口准照,約值1.5億美元設備並未出口。
《日本經濟新聞》早前報道,受影響中國客戶為中芯國際(00981.HK)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.